# A314 vs Ascend for interviews

**URL:** <https://pheromonetalk.com/t/a314-vs-ascend-for-interviews/61591>\
**Category:** Men's Pheromone Advice & Field Reports\
**Created:** [April 2, 2014, 12:12am UTC](https://pheromonetalk.com/t/a314-vs-ascend-for-interviews/61591 "2014-04-02T00:12:36Z")\
**Posts on this page:** 1\
**Showing post:** 7

<div class="post-metadata">

**Author:** ![monesmadedoit](https://sea2.discourse-cdn.com/flex016/user_avatar/pheromonetalk.com/monesmadedoit/32/325_2.png) [@monesmadedoit](https://pheromonetalk.com/u/monesmadedoit)\
**Post date:** [April 5, 2014, 1:44am UTC](https://pheromonetalk.com/t/a314-vs-ascend-for-interviews/61591/7 "2014-04-05T01:44:50Z")

</div>

I tried to evaluate the Ascend webpage. The page says “click on ingredients for certified analysis from independent lab.” I click on androsterone. Not there. Androstenone. Not there. XiSt has the three secret molecules that only people in the secret club get to learn about. If someone finds the GC-MS or HPLC reports, lemme know. I already know that at least one phero company is using not real analysis reports on their website. For five years now! Not saying XS is, just saying I cannot find the reports at all. For a status product mostly made of erone, yes, the quality and purity of the rone is a factor, as is the lab and the certified test report. And the synthesis.

> [@Will A314 be back in stock?](https://pheromonetalk.com/t/will-a314-be-back-in-stock/31278/9):
>
> I have a batch with an alternate synthesis of rone in it, batch 22. That might even be available at the LA office for shipment. It uses a completely different synthesis route of androsterone, with a different starting material, which means the “impurities” (the part almost nobody considers) should be very different. The reality of the matter is that the content of the impurities sometimes has a massive effect on the end result, when the impurities themselves are “actives”. I’ve talked at len…

---

_[View the full topic](https://pheromonetalk.com/t/a314-vs-ascend-for-interviews/61591)._
